Organization of the teicoplanin gene cluster in Actinoplanes teichomyceticus by Sosio, M. et al.
  
 University of Groningen
Organization of the teicoplanin gene cluster in Actinoplanes teichomyceticus





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2004
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Sosio, M., Kloosterman, H., Bianchi, A., de Vreugd, P., Dijkhuizen, L., & Donadio, S. (2004). Organization
of the teicoplanin gene cluster in Actinoplanes teichomyceticus. Microbiology-Sgm, 150(1), 95 - 102.
https://doi.org/10.1099/mic.0.26507-0
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Organization of the teicoplanin gene cluster in
Actinoplanes teichomyceticus
Margherita Sosio,1 Harm Kloosterman,2 Alessandra Bianchi,1




1Vicuron Pharmaceuticals, via R. Lepetit 34, 21040 Gerenzano, Italy
2Microbial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB),
University of Groningen, 9751 NN Haren, The Netherlands
Received 22 May 2003
Revised 12 September 2003
Accepted 3 October 2003
The glycopeptide teicoplanin is used for the treatment of serious infections caused by
Gram-positive pathogens. The tcp gene cluster, devoted to teicoplanin biosynthesis in the
actinomycete Actinoplanes teichomyceticus, was isolated and characterized. From sequence
analysis, the tcp cluster spans approximately 73 kb and includes 39 ORFs participating in
teicoplanin biosynthesis, regulation, resistance and export. Of these, 34 ORFs find a match in at
least one of the five glycopeptide gene clusters previously characterized. Putative roles could
be assigned for most of the tcp genes. The two glycosyltransferases responsible for attaching
amino sugars to amino acids 4 and 6 of the teicoplanin aglycon were overexpressed in Escherichia
coli and characterized. They both recognize N-acetylglucosamine as the substrate. tGtfA can
add a sugar residue in the presence or absence of N-acetylglucosamine at amino acid 4, while
tGtfB can only glycosylate the teicoplanin aglycon.
INTRODUCTION
The two clinically used glycopeptide antibiotics, teicoplanin
and vancomycin, interfere with bacterial cell wall synthesis
by binding to the D-alanyl-D-alanine termini of peptido-
glycan precursor, thus sequestering intermediate(s) during
bacterial cell wall formation. Glycopeptides are often a last
resort antibiotic for tough-to-treat infections by Gram-
positive bacteria. However, their effectiveness is threatened
by the possibility that the high-level resistance to glyco-
peptides frequent among enterococci may eventually become
widespread in methicillin-resistant Staphylococcus aureus.
Chemical modification of glycopeptides has led to the
development of semi-synthetic glycopeptide derivatives,
with improved activity, expanded antibacterial spectrum or
better pharmacokinetics (Malabarba & Ciabatti, 2001).
In recent years, considerable progress has been made in
understanding glycopeptide biosynthesis. Sequence informa-
tion is now available for five gene clusters: chloroeremo-
mycin (van Wageningen et al., 1998), balhimycin (Pelzer
et al., 1999; Recktenwald et al., 2002), complestatin (Chiu
et al., 2001), A47934 (Pootoolal et al., 2002) and A40926
(Sosio et al., 2003). Characterization of several gene
products overproduced in Escherichia coli and gene
inactivation experiments in the producing strain (reviewed
by Hubbard & Walsh, 2003) have established the details of
many biosynthetic steps. Most of this work has been carried
out on the pathways of chloroeremomycin and balhimycin,
two vancomycin-type glycopeptides.
Teicoplanin (Fig. 1, compound 1), produced by the actino-
mycete Actinoplanes teichomyceticus ATCC 31131, consists
of a complex of closely related molecules differing in the
nature of the acyl residue. A relevant structural feature
of teicoplanin is the presence of an N-acetylglucosamine
(GlcNAc) and an N-acylglucosamine residue attached to
amino acids 6 and 4, respectively. Glycosyltransferases
(GTFs) able to attach this type of sugar to glycopeptide
aglycons have not been described yet (Solenberg et al., 1997;
Losey et al., 2001, 2002). With the objective of understand-
ing the tailoring steps involved in decorating teicoplanin-
type aglycons, we describe here the entire tcp cluster and
report the overexpression of two active tcp GTF enzymes.
METHODS
Isolation of the tcp cluster. Using total DNA of the actinomycete
Actinoplanes teichomyceticus ATCC 31131, a cosmid library in the
pWE15 vector was made by the Clontech Laboratories custom
library service. The tcp cluster was identified as described previously
(Sosio et al., 2000). Cosmids were sequenced by the Seqlab custom
sequencing service. The DNA sequence was analysed with programs
from the Wisconsin Package (version 10, Accelrys). Each coding
sequence was then compared with the bal, cep, com, dbv and sta
Abbreviations: DPG, dihydroxyphenylglycine; GTF, glucosyltransferase;
HPG, p-hydroxyphenylglycine; bHT, b-hydroxytyrosine; NRPS, non-
ribosomal peptide synthetase; TFA, trifluoroacetic acid.
The GenBank accession number for the tcp gene sequence reported in
this article is AJ605139.
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clusters and searched against GenBank. Most likely start codons
were established by multiple alignment of related sequences, when-
ever possible, or by searching for ribosome-binding sites.
Expression of GTFs. The genes encoding the two tcp GTFs (tGtfA
and tGtfB) were amplified from cosmid DNA, using the following
primer pairs: 59-GCGCATATGCGCGTGCTGTTTTCGTCC-39 and
59-GCAGATCTTCACGCGGGAACCGACGATC-39 for gtfA, 59-GC-
GCATATGCGTGTGTTGTTGTCGACGAC-39 and 59-CGCAGATCT-
CACGCGGAGACCGACGATCTCT-39 for gtfB. Forward and reverse
primers introduced an NdeI and a BglII restriction site (underlined),
respectively, into the PCR fragment. PCR reactions were carried out
using Vent DNA polymerase (New England Biolabs) as described by
the supplier. After NdeI and BglII digestion, the PCR fragments were
cloned into the corresponding sites of the pET3B and pET15B
expression vectors (Novagen), yielding the following constructs:
ptGTFA, ptGTFB, pHis6tGTFA and pHis6tGTFB. All constructs were
sequenced to ensure that no amplification errors had been intro-
duced. These plasmids were introduced into E. coli BL21(DE3)-star
(Stratagene). Subsequently, transformants were transferred to LB
medium supplemented with 1 M sorbitol and incubated for 24 h
at 30 uC. Cultures were centrifuged, washed and resuspended in
50 mM Tris/HCl buffer (pH 9). Cells were disrupted by two pas-
sages through a French pressure cell operated at 140 MPa. Crude
extracts were prepared by centrifugation for 30 min at 40 000 g.
GTF activity assays and product analysis. Enzymic activity was
assayed in a total volume of 100 ml, containing 1 mmol UDP-
GlcNAc and 100 nmol aglycon in 50 mM Tris/HCl buffer (pH 9)
and a variable amount of cell extracts containing either or both
tGtfA and tGtfB proteins. Reactions were incubated at 37 uC. After
reaction termination on ice, products were identified with an ana-
lytical HPLC using an AlphaBond C18 column (25064?6 mm,
Alltech), applying a linear gradient from 1% (v/v) acetonitrile in
0?1% TFA to 33% acetonitrile in 0?1% TFA over 15 min at a
1 ml min21 flow rate, with UV detection at 280 nm. Products
formed in assays with combined extracts were analysed using a
linear gradient from 1% acetonitrile in 0?1% TFA to 12% acetoni-
trile in 0?1% TFA over 15 min. New product peaks were analysed
by HPLC-MS, by delivering 10% of the post HPLC-column flow to
a Navigator quadrupole mass spectrometer (Finnigan). Mass spectral
analysis was performed in the positive-ion mode of an ESI mass
spectrometer, operating over a range of 1150–1650 a.m.u. Nitrogen
was used as nebulizing and drying gas. Ions were accelerated in a
25 V electric field. The teicoplanin aglycon and (pseudo)aglycon
(compounds 2 and 4 in Fig. 1, respectively) have been described
(Malabarba et al., 1984) and were kindly provided by Sonia Maffioli
(Vicuron Pharmaceuticals).
RESULTS
Organization of the tcp cluster
From a 110 kb segment from the A. teichomyceticus genome
(Sosio et al., 2000), we sequenced a contiguous stretch of
89 713 nt. The probable boundaries of the tcp cluster were
established from the deduced functions of the tcp gene
products. On its left end (Fig. 2), the tcp cluster is likely to be
delimited by ORF1, encoding a homologue of MurF, the
D-alanyl-D-alanine-adding enzyme involved in cell wall
formation (Table 1). On the right side, the tcp cluster is
probably delimited by ORF39, encoding a type II thioester-
ase (Table 1). Consequently, a total of 39 ORFs define the
tcp cluster, which spans almost 74 kb. The genetic organiza-
tion of the tcp cluster is depicted in Fig. 2, and the relevant
features of the 39 tcp ORFs are summarized in Table 1. The
functions of the tcp genes were established by sequence
comparison with homologues from other glycopeptide
clusters. This analysis is reported below, grouping the tcp
ORFs by their putative roles.
Synthesis of specialized amino acids
Apart from the Tyr residue at position 2, the heptapeptide
skeleton of teicoplanin consists of non-proteinogenic amino
acids: three p-hydroxyphenylglycine (HPG) residues (at posi-
tions 1, 4 and 5); two dihydroxyphenylglycine (DPG) at
positions 3 and 7; and one b-hydroxytyrosine (bHT) at
position 6. Seven tcp genes participate in the synthesis of
Fig. 1. Structures of teicoplanin and related (pseudo)-aglycons.
96 Microbiology 150
M. Sosio and others
HPG and DPG. ORF37 and ORF38 encode p-hydroxy-
mandelate synthetase (HmaS) and p-hydroxymandelate oxi-
dase (Hmo), respectively, for HPG formation (Hubbard et al.,
2000; Li et al., 2001); ORFs 30 to 33 encode DpgA to DpgD,
respectively, required for DPG synthesis (Chen et al., 2001;
Pfeifer et al., 2001); and ORF36 encodes the Tyr-dependent
aminotransferase HpgT, required for the transamination of
both p-hydroxyphenylglyoxylate and 3,5-dihydroxyphenyl-
glyoxylate, to yield HPG and DPG, respectively (Hubbard
et al., 2000; Pfeifer et al., 2001). Thus, synthesis of HPG and
DPG requires the same seven functions in all glycopeptide
clusters that direct the synthesis of these two amino acids.
Synthesis of bHT probably involves the product of tcp
ORF25, a putative non-haem iron dioxygenase (Table 1).
Homologues of this ORF are present in the dbv and sta
clusters, but not in the bal and cep clusters. Thus, a common
route for bHT formation seems to operate in teicoplanin,
A47934 and A40926 biosyntheses, which differs from the
balhimycin and chloroeremomycin case, where tyrosine is
converted into bHT through the action of three enzymes
(Chen & Walsh, 2001; Puk et al., 2002).
Synthesis of the heptapeptide precursor
Synthesis of the teicoplanin heptapeptide precursor is carried
out by a non-ribosomal peptide synthetase (NRPS). These
enzyme systems are organized inmodules, with eachmodule
responsible for the recognition and incorporation of one
amino acid into the oligopeptide (Marahiel, 1997). Within
each module, the adenylation (A) domain is responsible for
substrate recognition and activation, the thiolation (T)
domain for forming a thioester bond with the cognate
amino acid and elongating peptide, and the condensation
(C) domain for catalysing peptide bond formation. In
addition, an epimerization (E) domain is found in those
modules epimerizing L-amino acids into their D-forms. The
last module is usually completed by a thioesterase (Te)
domain, which hydrolyses the thioester bond linking the
completed peptide to the NRPS.
Four proteins, encoded by ORFs 9 to 12, constitute the
seven-module teicoplanin NRPS. The genetic organization
and domain composition of these ORFs indicate that ORF9,
encoding the A-T-C-A-T-E domains, specifies modules 1
and 2; ORF10 (C-A-T) module 3; ORF11 (C-A-T-E-C-A-T-
E-C-A-T) modules 4 to 6; and ORF12 (C-A-T-X*-Te, where
X* denotes an atypical C or E domain of unknown function,
so far present in all glycopeptide NRPSs) module 7. Thus,
the tcp NRPS shows an overall domain composition
identical to that of the bal, cep and dbv systems. Only the
com and sta NRPSs present an E domain at the end of
module 3, unexpected from the L-stereochemistry of the
third amino acid of the heptapeptide in all glycopeptides.
Three other tcp ORFs are likely to participate in heptapep-
tide synthesis. ORFs 13 and 17 (Table 1) each encode a 69 aa
polypeptide of unknown function, which is specified by
an ORF located downstream of the NRPS gene encoding
module 7 in the other glycopeptide clusters. The two poly-
peptides are completely identical over the first 60 aa, and
present only 6 amino acid substitutions over their entire
length. In addition, also the first 181 nt of the two ORFs are
perfectly identical, suggesting that one copy arose from
duplication of the other. The other ORF that may be
indirectly involved in heptapeptide synthesis is ORF39,
Fig. 2. Genetic organization of the tcp cluster. Each ORF is represented by an arrow, and numbered as in Table 1. Numbers
on the scale bars indicate sequence coordinates (in kb).
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which encodes a type II thioesterase (Table 1). The
proposed role for these thioesterases is to hydrolyse
misprimed or misacylated T domains (Heathcote et al.,
2001; Schwarzer et al., 2002). A type II thioesterase-
encoding gene is also present towards one end of the dbv
cluster, but not in the bal, cep, com or sta clusters.
Cross-linking and halogenation of the aromatic
residues
Teicoplanin contains three ether links (between amino acids
1-3, 2-4 and 4-6) and one C–C link (between amino acids 5-
7) joining its aryl groups. These cross-linking reactions are
Table 1. tcp ORFs
tcp ORF* Glycopeptide clustersD GenBankd Proposed
function
ORF Size§ bal cep com dbv sta Match Score
1 447 + D-Alanyl-D-alanine adding enzyme
2 405 + D-Lactate dehydrogenase
3 345 + D-Alanine : D-lactate ligase
4 202 + D-Alanyl-D-alanine dipeptidase
5 179 ZP_00050635.1 9e213 Unknown
6 363 + + + Sensory kinase
7 226 + + + Response regulator
8 393 + + Glycosyltransferase GtfA
9 2076 + + + + + NRPS, modules 1–2
10 1061 + + + + + NRPS, module 3
11 4067 + + + + + NRPS, modules 4–6
12 1865 + + + + + NRPS, module 7
13 69 + + + + + Unknown
14 273 + + + Unknown
15 593 + Mannosyltransferase
16 646 + + + + + ABC transporter
17 69 + + + + + Unknown (related to tcp ORF13)
18 391 + + + + + OxyA, cross-linking aa 2-4
19 384 + + Oxy, cross-linking aa 1-3
20 398 + + + + + OxyB, cross-linking aa 4-6
21 506 + + + + + Halogenase
22 392 + + + + OxyC, cross-linking aa 5-7
23 408 + + + Glycosyltransferase GtfB
24 323 + Unknown
25 530 + + b-Hydroxylase
26 598 BAB69270.1 5e288 Acyl-CoA ligase
27 351 NP_228154.1 8e296 Chorismate mutase
28 329 + + + + + Regulator
29 792 AAC38065 Regulator
30 373 + + + + DpgA
31 221 + + + + DpgB
32 433 + + + + DpgC
33 268 + + + + DpgD
34 453 + + + + + Integral membrane transporter
35 198 NP_505710.1 7e242 GTP cyclohydrolase
36 365 + + + + + Aminotransferase HpgT
37 351 + + + + + HmaS
38 364 + + + + + Hmo
39 250 + Type II thioesterase
*tcp ORFs as in Fig. 2.
DHomologues in other glycopeptide clusters: ‘+’ denotes presence.
dBest match found by BLAST searches in GenBank, other than glycopeptide clusters, with match referring to the accession number and score to
the probability score of the match.
§Length in amino acid residues.
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carried out by P450mono-oxygenases (Bischoff et al., 2001a,
b), and the tcp cluster, like the sta and dbv clusters, contains
four such oxy genes, designated ORFs 18, 19, 20 and 22
(Table 1). It is therefore reasonable to assume that each Oxy
protein carries a distinct cross-linking reaction. On the basis
of the model proposed for the bal Oxy proteins (Bischoff
et al., 2001b) and using sequence similarity as the criterion,
it is likely that ORF18 (77% identical to bal-OxyA, but no
more than 42% identical to the other Oxy proteins) is
involved in the cross-linking of the aromatic residues of
amino acids 2 and 4; ORF20 (76% identical to bal-OxyB,
but no more than 50% identical to the other Oxy proteins)
in cross-linking of amino acids 4 and 6; and ORF22 (70%
identical to bal-OxyC, but no more than 47% identical
to the other Oxy proteins) for amino acids 5 and 7. By
exclusion, ORF19 should be involved in cross-linking of
amino acids 1-3.
Teicoplanin contains two chlorine atoms, one on the Tyr
residue at position 2 and the other on the bHT residue at
position 6. The product of ORF21 (Table 1) is highly related
to other halogenases involved in chlorination of aromatic
residues in glycopeptide biosynthesis (Puk et al., 2002;
Sosio et al., 2003). Thus, a single halogenase should modify
both residues.
Addition of sugars
Teicoplanin contains an N-acylglucosamine attached to the
hydroxyl group of amino acid 4; a GlcNAc attached to the b-
hydroxy of amino acid 6; and a mannose residue attached to
one of the hydroxyl groups of amino acid 7. The roles of
the two NDP-dependent GTFs encoded by ORFs 8 and 23
(Table 1) are described below. As proposed for the dbv
cluster (Sosio et al., 2003), mannosylation is likely to be
carried out by a different type of GTF, unrelated to the tGtfA
and tGtfB proteins described below. The putative manno-
syltransferase encoded by the tcp cluster is specified by
ORF15 (Table 1).
Resistance, export, regulation and unknown
functions
The above analysis accounts for 23 of the 39 tcp genes. Seven
of the remaining 16 ORFs are grouped at the left end of the
tcp cluster, where the vanHAX-like glycopeptide-resistance
cassette (ORFs 2 to 4) is located next to a murF homologue
(Sosio et al., 2000). Thus, the sta and tcp cluster share the
same set of four genes at one end of the cluster, although
they are differently organized. At least in the A47934 pro-
ducer Streptomyces toyocaensis, these genes are important in
conferring glycopeptide resistance (Pootoolal et al., 2002).
In vancomycin-resistant enterococci, homologues of ORFs 2
to 4 are involved in the synthesis of the D-alanyl-D-lactate
moiety at the termini of the pentapeptide chains in nascent
peptidoglycan, thus reducing the extent of glycopeptide
binding to its molecular target (Evers et al., 1996). ORFs 2 to
4 are therefore likely to be involved in conferring some level
of teicoplanin resistance to the producing strain. It remains
to be established whether ORF1, specifying a putative D-
alanyl-D-alanine-adding enzyme, plays any role in confer-
ring glycopeptide resistance.
ORFs 16 and 34 are likely to specify export functions, since
they are predicted to encode an ABC-type and an ion-
dependent transmembrane transporter, respectively (Table 1).
ORFs 6 and 7 encode the response regulator and the sensor
kinase, respectively, of a likely two-component signal trans-
duction system (Table 1). The product of ORF28 belongs to
the family of StrR-type positive transcriptional regulators,
while ORF29 specifies a positive regulator of the LuxR
family (Table 1).
ORFs 5, 14, 24, 26, 27 and 35 complete the list of tcp genes
(Table 1). ORF5 is related to a protein of unknown function
from Amycolatopsis orientalis, which however lies outside
the cep cluster. ORFs 14 and 24 find matches in other glyco-
peptide clusters: the former is specified by the bal, cep and
dbv clusters, while the latter only by the dbv cluster. ORF26
encodes a putative acyl-CoA ligase, while ORF27 encodes
a putative 3-deoxy-D-arabino-heptulosonate 7-phosphate
synthase of the AroA type, unrelated to the equivalent poly-
peptide encoded by the cep cluster. Finally, ORF35 shows
considerable sequence identity to type I GTP cyclohydrolases.
Expression of GTFs
The gene composition of the tcp cluster makes it very likely
that this region is indeed involved in the synthesis of a
glycopeptide antibiotic. Since no methods for the genetic
manipulation of A. teichomyceticus have been described, we
sought to provide direct evidence for the function of selected
tcp genes through heterologous expression. Of the two
NDP-dependent GTFs identified in the tcp cluster, ORF8 is
most related to GtfA proteins, typically glycosylating amino
acid 6, and ORF23 to GtfBs, which specifically glycosylate
amino acid 4. In order to establish their roles, both genes
were cloned in the expression vectors pET3b and pET15B
(the latter introducing an N-terminal His6 tag). SDS-PAGE
analysis of centrifuged E. coli extracts revealed that both
proteins, without the N-terminal His-tag, were expressed
in E. coli cultivated in LB at 37 uC, but large amounts of
insoluble protein were present in the pellet fractions. Also
the His-tagged version of tGtfB yielded high amounts of
insoluble protein, while no His6-tGtfA expression was
observed in E. coli. Addition of 1 M sorbitol to the growth
medium and decreasing the cultivation temperature from 37
to 30 uC resulted in a clear shift from insoluble to soluble
proteins for tGtfA, tGtfB and His6-tGtfB (data not shown).
However, the altered cultivation conditions did not lead
to detectable His6-tGtfA protein. The use of compatible
solutes, such as sorbitol, to stimulate correct protein folding
and counteract inclusion body formation, has been des-
cribed previously (Barth et al., 2000).
Incubations of E. coli extracts expressing tGtfA with teico-
planin aglycon (Fig. 1, compound 2) and UDP-GlcNAc
resulted in the appearance of a new HPLC product peak
http://mic.sgmjournals.org 99
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(Fig. 3, trace C). No product was observed in incubations of
extracts derived from E. coli-pET3b cells (Fig. 3, trace A).
The retention time of the tGtfA-dependent peak coincided
with that of authentic compound 4 (Fig. 3, trace E).
Consistently, HPLC-MS experiments indicated that the
molecular mass of the tGtfA product peak was 1400?3,
confirming that tGtfA transforms compound 2 into
compound 4 (Fig. 1). Incubation of the E. coli cell extracts
expressing tGtfB or His6-tGtfB with teicoplanin aglycon
and UDP-GlcNAc revealed the appearance of a novel
peak (Fig. 3, trace B), with a different retention time from
compound 4 but with identical molecular mass. This result
suggests that tGtfB adds a GlcNAc moiety to a different
position in the teicoplanin aglycon, most likely yielding
compound 3 in Fig. 1. To determine whether the combined
action of tGtfA and tGtfB produces a double glycosylated
aglycon, crude extracts of both proteins were combined in
one assay. HPLC analysis showed that this incubation
yielded three product peaks, two of which corresponded to
the products observed previously in single tGtf-incubations.
The retention time of the novel product peak was very close
to that of compound 3 (Fig. 3, trace D). To achieve a reason-
able separation of both compounds, a shallow gradient was
applied, which yielded retention times of 9?2 and 8?7 min
for compound 3 and the third product peak, respectively
(Fig. 4). MS analysis of the 8?7 min product peak yielded
a molecular mass of 1603?4, as expected from compound
5 (Fig. 1). The abundance of this peak increased with
incubation time (Fig. 4).
When compound 4 replaced the teicoplanin aglycon in the
incubation mixtures, tGtfB was unable to produce a new
HPLC peak (Fig. 3, trace F), suggesting that compound 4 is
not a substrate for this enzyme. As expected, no conversion
of compound 4 was observed with tGtfA (data not shown).
When cell extracts containing either tGtfA or tGtfB were
incubated with vancomycin aglycon and UDP-GlcNAc, no
HPLC product peak was observed, not even after 24 h
incubation. This is in contrast with the cep-encoded GtfB
enzyme, which also glycosylates the teicoplanin aglycone at
amino acid 4 (Losey et al., 2001, 2002). UDP-sugar substrate
specificity was tested for both tGtf enzymes in incubations
with teicoplanin aglycon. The activated sugars tested were:
UDP-N-acetylgalactosamine, U/TDP-glucose and UDP-
galactose. No conversion of teicoplanin aglycon was found
with any of these activated sugars.
DISCUSSION
We have described here the complete tcp cluster and pro-
vided a first characterization of the activities and substrate
specificities of two NDP-sugar-dependent GTFs encoded by
this cluster. A total of five gene clusters (bal, cep, dbv, sta and
tcp) involved in the synthesis of antibacterial glycopeptides
have now been described, in addition to the com cluster
directing formation of an anti-complement glycopeptide.
These clusters derive from four different genera of actino-
mycetes (Actinoplanes, Amycolatopsis, Nonomuraea and
Streptomyces). It should be noted that, despite the very
similar chemical structures of the two glycopeptides A40926
and teicoplanin, only 28 of the 39 ORFs specified by the tcp
cluster find a homologue in the dbv cluster (Table 1).
One unique feature of the tcp cluster is the lack of an ORF
encoding a putative prephenate dehydrogenase (PDH).
PDH-encoding ORFs have been observed so far in the five
other glycopeptide clusters, as well as in the cda (Hojati et al.,
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Fig. 4. Analysis of double-glycosylated aglycon. HPLC analysis
(using a shallower gradient as described under Methods) of
the products obtained from the combined E. coli/ptGTFB and
/ptGTFA extracts, after 4 and 20 h incubation. Peak numbers























Fig. 3. GTF analysis. HPLC analysis of the incubation mixtures
containing teicoplanin aglycon and UDP-GlcNAc as substrates,
and either E. coli/pET3b (A), /ptGTFB (B), /ptGTFA (C) or
combined /ptGTFB and /ptGTFA (D) extracts. Authentic
compounds 4 and 2 are shown in (E). HPLC analysis of an
incubation mixture containing authentic compound 4 and UDP-
GlcNAc as substrates with E. coli-ptGTFB is shown in (F). All
analyses were performed after 4 h incubation. Peaks are num-
bered in accordance with compound numbering of Fig. 1.
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from Streptomyces coelicolor and Actinoplanes sp. ATCC
33076, respectively. The corresponding compounds contain
an HPG residue. The presumed role of PDH is to prime
HPG synthesis by generating p-hydroxyphenylpyruvate
(HPP), the first substrate for the enzyme Hmo. It should
be noted that, using Tyr as an amino donor, HpgT generates
one molecule of HPP. In the actinomycetes where this has
been investigated, Tyr biosynthesis requires an arogenase,
which converts prephenate into arogenate (Hodgson, 2000).
In addition, the S. coelicolor genome (Bentley et al., 2002)
contains a single PDH-encoding gene within the cda cluster.
We do not know whether A. teichomyceticus possesses a
PDH-encoding gene somewhere else in its genome.
However, it should be noted that, in those glycopeptides
where both HPG and DPG are utilized, HPP can be formed
by transamination of Tyr during DPG formation. Thus, a
PDH activity may be strictly necessary only in those cases
when HPG synthesis is unlinked to that of DPG.
The gene(s) responsible for N-acylation of the glucosamine
residue have not been identified. Contrary to our expecta-
tions, the tcp cluster specifies no homologue of dbv ORF23,
which contains motifs typical of the family 3 of acyltrans-
ferases (Sosio et al., 2003) and could have been a likely
candidate for carrying out this reaction. Instead, the tcp
cluster specifies a putative acyl-CoA ligase, encoded by
ORF26 (Table 1). If N-acylation is carried out by homo-
logous genes during teicoplanin and A40926 biosynthesis,
then the dbv and tcp clusters should share a gene absent from
the other glycopeptide clusters. The only ORFs of unas-
signed function fitting this requirement are represented by
tcp ORF24 and dbv ORF8. However, these sequences show
no homology in database searches. An alternative possibility
is that N-acylation is carried out through different mechan-
isms in A40926 and teicoplanin formation. The existence of
two different pathways for bHT formation represents a
precedent in glycopeptides.
We observed that compound 5 is formed by the combined
action of tGtfA and tGtfB while compound 4 is not a
substrate for tGtfB. This suggests that tGtfA can glycosylate
the teicoplanin molecule independently of the glycosylation
at amino acid 4, while tGtfB can act only on the aglycon.
This would imply that tGtfB acts before tGtfA during
teicoplanin biosynthesis in A. teichomyceticus. In vivo studies
with the balhimycin producer indicated that a bgtfB deletion
mutant produced only the balhimycin aglycon (Pelzer et al.,
1999), suggesting that bGtfA is unable to attach epi-
vancosamine to amino acid 6. If this is true also in vitro, it
would mean that bGtfA, unlike tGtfA, can only recognize a
balhimycin pseudoaglycon glucosylated at amino acid 4.
A second finding is that tGtfB recognizes UDP-GlcNAc
as the substrate. Since we did not have access to UDP-
glucosamine, we do not know whether this reflects a relaxed
specificity by tGtfB. The alternative possibility is that UDP-
GlcNAc is the true substrate for tGtfB, and then a trans-
acylation reaction replaces the acetyl group on this sugar
with the fatty acid chain found in teicoplanin. This latter
hypothesis is also consistent with the utilization of UDP-
GlcNAc by several cellular pathways, while we are unaware
of instances where bacterial metabolism uses an NDP-
activated glucosamine.
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